The Effects of Lung-Moistening Herbal Medicines on Bleomycin-Induced Pulmonary Fibrosis Mouse Model

被引:4
|
作者
Ahn, Junmo [1 ]
Joo, Hyejin [2 ]
Park, Jihye [3 ]
Park, Jae-Woo [1 ]
Kim, Kwan-Il [1 ]
Jung, Hee-Jae [1 ]
Bu, Youngmin [1 ]
Lee, Beom-Joon [1 ]
机构
[1] Kyung Hee Univ, Coll Korean Med, Seoul 02447, South Korea
[2] Kyung Hee Univ, Grad Sch, Coll Sci Korean Med, Seoul 02447, South Korea
[3] Kyung Hee Univ, Grad Sch, Dept Biomed Sci & Technol, Seoul 02447, South Korea
基金
新加坡国家研究基金会;
关键词
pulmonary fibrosis; bleomycin; herbal medicine; broncho alveolar lavage fluid; inflammation; DIAGNOSIS;
D O I
10.3390/pr8010102
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
In traditional medicine, lung-moistening herbal medicines (LMHM) are regarded as a major option for treating symptoms of pulmonary fibrosis (PF) including dry cough and dyspnea. As PF agents are being applied to the development of lung cancer agents, PF and lung cancer are reported to have high pathological and pharmacological relationships. This study was proposed to identify candidates for the treatment of PF via investigating the effect of LMHM on PF mouse model. PF was induced by intratracheal instillation of bleomycin. Six water extracts of LMHM such as Farfarae Flos (FAF), Trichosanthis Semen (TRS), Lilii Bulbus (LIB), Adenophorae Radix (ADR), Asteris Radix (ASR), and Scrophulariae Radix (SCR) were prepared and administered (300 mg/kg) orally for 10 days after induction. The changes in body weight, histopathology, and immune cell of bronchoalveolar lavage fluid (BALF) were investigated. Among those, LIB and ADR significantly decreased the deposition of collagen and septal thickness of alveolar and terminal bronchiole. Moreover, SCR, TRS, LIB, and ADR decreased total cells, macrophages, and lymphocytes in BALF. Taken together, ADR and LIB could be the candidates to reduce PF. Further studies on their effects at different doses and analysis of their underlying molecular mechanisms are needed.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Ameliorative Effects of Atorvastatin on Bleomycin-Induced Pulmonary Fibrosis in Rats
    Hemmeti, Ali Asghar
    Zerafatfard, Mohammad Rahim
    Goudarzi, Mehdi
    Khodayar, Mohammad Javad
    Rezaie, Anahita
    Nooshabadi, Mohammad Reza Rashidi
    Kiani, Milad
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2016, 11 (04)
  • [22] Elastase modifies bleomycin-induced pulmonary fibrosis in mice
    Silva Neto Trajano, Larissa Alexsandra
    Lima Trajano, Eduardo Tavares
    Lanzetti, Manuella
    Amorim Mendonca, Morena Scopel
    Guilherme, Rafael Freitas
    Figueiredo, Rodrigo Tinoco
    Benjamim, Claudia Farias
    Valenca, Samuel Santos
    Alto Costa, Andrea Monte
    Porto, Luis Cristovao
    ACTA HISTOCHEMICA, 2016, 118 (03) : 203 - 212
  • [23] Serial Micro-CT Assessment of the Therapeutic Effects of Rosiglitazone in a Bleomycin-Induced Lung Fibrosis Mouse Model
    Choi, Eun Jung
    Jin, Gong Yong
    Bok, Se Mi
    Han, Young Min
    Lee, Young Sun
    Jung, Myung Ja
    Kwon, Keun Sang
    KOREAN JOURNAL OF RADIOLOGY, 2014, 15 (04) : 448 - 455
  • [24] Effects of plant extracts and bioactive compounds on attenuation of bleomycin-induced pulmonary fibrosis
    Hosseini, Sarasadat
    Imenshahidi, Mohsen
    Hosseinzadeh, Hossein
    Karimi, Gholamreza
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 : 1454 - 1465
  • [25] Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice
    Shariati, Saeedeh
    Kalantar, Hadi
    Pashmforoosh, Marzieh
    Mansouri, Esrafil
    Khodayar, Mohammad Javad
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
  • [26] Characterization of lung stem cell niches in a mouse model of bleomycin-induced fibrosis
    Ena Ray Banerjee
    William Reed Henderson
    Stem Cell Research & Therapy, 3
  • [27] Tetrathiomolybdate Treatment Attenuates Bleomycin-Induced Angiogenesis and Lung Pathology in a Sheep Model of Pulmonary Fibrosis
    Derseh, Habtamu B.
    Perera, Kopiyawaththage U. E.
    Dewage, Sasika N. Vithana
    Stent, Andrew
    Koumoundouros, Emmanuel
    Organ, Louise
    Pagel, Charles N.
    Snibson, Ken J.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [28] Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis
    Gharaee-Kermani, M
    Nozaki, Y
    Hatano, K
    Phan, SH
    CYTOKINE, 2001, 15 (03) : 138 - 147
  • [29] Indocyanine-enhanced mouse model of bleomycin-induced lung fibrosis with hallmarks of progressive emphysema
    Grandi, Andrea
    Ferrini, Erica
    Mecozzi, Laura
    Ciccimarra, Roberta
    Zoboli, Matteo
    Leo, Ludovica
    Khalajzeyqami, Zahra
    Kleinjan, Alex
    Lowik, Clemens W. G. M.
    Donofrio, Gaetano
    Villetti, Gino
    Stellari, Franco Fabio
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2023, 324 (02) : L211 - L227
  • [30] Effects of erdosteine on bleomycin-induced lung fibrosis in rats
    Boyaci, H
    Maral, H
    Turan, G
    Basyigit, I
    Dillioglugil, MÖ
    Yildiz, F
    Tugay, M
    Pala, A
    Erçin, C
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2006, 281 (1-2) : 129 - 137